These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 2165168)

  • 21. In vitro synergistic effects of fisetin and norfloxacin against aquatic isolates of Serratia marcescens.
    Dong J; Ruan J; Xu N; Yang Y; Ai X
    FEMS Microbiol Lett; 2016 Jan; 363(1):fnv220. PubMed ID: 26567906
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Drug resistance, R plasmids and pigmentation of Serratia marcescens isolated in Taiwan.
    Ding MJ; Sung SJ
    Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1987 Feb; 20(1):69-79. PubMed ID: 3297535
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Detection of the plasmid-mediated quinolone resistance determinants in clinical isolates of Serratia marcescens in China.
    Yang HF; Cheng J; Hu LF; Ye Y; Li JB
    J Antibiot (Tokyo); 2012 Oct; 65(10):531-3. PubMed ID: 22854338
    [No Abstract]   [Full Text] [Related]  

  • 24. Role of the outer membrane in the accumulation of quinolones by Serratia marcescens.
    Berlanga M; Ruiz N; Hernandez-Borrell J; Montero T; Viñas M
    Can J Microbiol; 2000 Aug; 46(8):716-22. PubMed ID: 10941517
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intraphagocytic bactericidal activity of ofloxacin compared with that of aztreonam and ceftriaxone against Serratia marcescens.
    Traub WH; Spohr M; Bauer D
    Zentralbl Bakteriol Mikrobiol Hyg A; 1986 Feb; 261(1):85-94. PubMed ID: 3518296
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Susceptibility of recent clinical isolates to temafloxacin (A-63004) and other antimicrobial agents.
    Qadri SM; Ueno Y; Burns JJ; Almodovar E; Rabea N
    Drugs Exp Clin Res; 1992; 18(8):311-7. PubMed ID: 1338041
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Effect of nalidixic acid and mitomycin C on growth and biosynthesis of extracellular proteins by Serratia marcescens].
    Iusupova DV; Sokolova RB; Petukhova EV
    Antibiot Khimioter; 1993; 38(8-9):16-21. PubMed ID: 8037570
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Function of the SOS process in repair of DNA damage induced by modern 4-quinolones.
    Howard BM; Pinney RJ; Smith JT
    J Pharm Pharmacol; 1993 Jul; 45(7):658-62. PubMed ID: 7692035
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nalidixic acid susceptibility testing of clinical isolates of Serratia marcescens.
    Jollick JD; Schervish-Swierkosz EM; Brown WJ
    Antimicrob Agents Chemother; 1973 Nov; 4(5):532-7. PubMed ID: 4598848
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [In vitro comparative activity of norfloxacin in the comparison of pathogenic bacteria of the urinary tract].
    Carlone NA; Cuffini AM; Tullio V; Savoia D; Cavallo GP
    G Batteriol Virol Immunol; 1986; 79(1-6):85-97. PubMed ID: 3479370
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antibacterial activity of a 1,8-naphthyridine quinolone, PD 131628.
    Lewin CS
    J Med Microbiol; 1992 May; 36(5):353-7. PubMed ID: 1316970
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Activity of 5 fluoroquinolones on hospital Gram-negative bacilli with different sensitivities to pefloxacin].
    Aubert G; Puech C; Lucht F; Loboguerrero M; Denis M; Dorche G
    Pathol Biol (Paris); 1989 Oct; 37(8):881-7. PubMed ID: 2515519
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antagonism between bactericidal activities of 4-quinolones and coumarins gives insight into 4-quinolone killing mechanisms.
    Howard BM; Pinney RJ; Smith JT
    Microbios; 1994; 77(311):121-31. PubMed ID: 8152392
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of salicylates on antibiotic sensitivity.
    Esposito S; Noviello S; Maggiolo F
    J Chemother; 1990 Apr; 2(2):87-90. PubMed ID: 2163438
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In vitro investigations on the action fosfomycin alone and in combination with other antibiotics on Pseudomonas aeruginosa and Serratia marcescens.
    Ullmann U; Lindemann B
    Arzneimittelforschung; 1980; 30(8):1247-9. PubMed ID: 6776966
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Sensitivity of Serratia marcescens to chemotherapy].
    Neguţ M; Niţulescu A; Potcoavă R
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Bacteriol Virusol Parazitol Epidemiol; 1978; 23(1):27-36. PubMed ID: 349661
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prevalence and diversity of qnr alleles in AmpC-producing Enterobacter cloacae, Enterobacter aerogenes, Citrobacter freundii and Serratia marcescens: a multicentre study from Korea.
    Park YJ; Yu JK; Lee S; Oh EJ; Woo GJ
    J Antimicrob Chemother; 2007 Oct; 60(4):868-71. PubMed ID: 17660263
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mechanisms of action of and resistance to ciprofloxacin.
    Hooper DC; Wolfson JS; Ng EY; Swartz MN
    Am J Med; 1987 Apr; 82(4A):12-20. PubMed ID: 3034057
    [TBL] [Abstract][Full Text] [Related]  

  • 39. HasF, a TolC-homolog of Serratia marcescens, is involved in energy-dependent efflux.
    Kumar A; Worobec EA
    Can J Microbiol; 2005 Jun; 51(6):497-500. PubMed ID: 16121228
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Interactions of antimicrobial drugs and combined phagocytic/serum bactericidal activity of defibrinated human blood against Serratia marcescens. IV. N-formimidoyl thienamycin.
    Traub WH
    Chemotherapy; 1983; 29(2):121-7. PubMed ID: 6340990
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.